cachexia
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | |||
| cachexia [2026/07/10 08:25] – [role of the vagal nerve] gary1 | cachexia [2026/09/02 13:14] (current) – [IL-6 as mediator of brain dysfunction and cachexia in cancer patients] gary1 | ||
|---|---|---|---|
| Line 14: | Line 14: | ||
| * using CRISPR to reduce the levels of IL-6 receptors in AP neurons | * using CRISPR to reduce the levels of IL-6 receptors in AP neurons | ||
| * see also: [[il-6]] | * see also: [[il-6]] | ||
| + | |||
| + | =====ADAMTSL4===== | ||
| + | *ADAMTSL4 is a protein secreted by tumours activates the TGF-β signaling pathway in muscle and fat tissue, thereby triggering a catabolic program and appears to be another driver of cachexia in cancer patients((https:// | ||
| =====role of growth differentiation factor 15 (GDF15)===== | =====role of growth differentiation factor 15 (GDF15)===== | ||
cachexia.txt · Last modified: 2026/09/02 13:14 by gary1